Your browser doesn't support javascript.
loading
Efficacy of ixekizumab on nail psoriasis in paediatric patients with moderate-to-severe psoriasis: a post hoc analysis from IXORA-PEDS.
Seyger, M M B; Reich, A; El Baou, C; Schuster, C; Riedl, E; Paller, A S.
Afiliação
  • Seyger MMB; Department of Dermatology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.
  • Reich A; Department of Dermatology, Institute of Medical Sciences, Medical College of Rzeszow University, Rzeszow, Poland.
  • El Baou C; Eli Lilly and Company, Indianapolis, IN, USA.
  • Schuster C; Eli Lilly and Company, Indianapolis, IN, USA.
  • Riedl E; Department of Dermatology, Medical University of Vienna, Vienna, Austria.
  • Paller AS; Eli Lilly and Company, Indianapolis, IN, USA.
J Eur Acad Dermatol Venereol ; 35(12): e911-e913, 2021 Dec.
Article em En | MEDLINE | ID: mdl-34320259
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Fármacos Dermatológicos / Doenças da Unha Limite: Child / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Fármacos Dermatológicos / Doenças da Unha Limite: Child / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article